| Q90394655 | A Link between Genetic Disorders and Cellular Impairment, Using Human Induced Pluripotent Stem Cells to Reveal the Functional Consequences of Copy Number Variations in the Central Nervous System-A Close Look at Chromosome 15 |
| Q38809416 | Are reprogrammed cells a useful tool for studying dopamine dysfunction in psychotic disorders? A review of the current evidence |
| Q38820880 | Controlling the Regional Identity of hPSC-Derived Neurons to Uncover Neuronal Subtype Specificity of Neurological Disease Phenotypes |
| Q27024122 | Drug repositioning approaches for the discovery of new therapeutics for Alzheimer's disease |
| Q36678789 | Functional Neurons Generated from T Cell-Derived Induced Pluripotent Stem Cells for Neurological Disease Modeling |
| Q26269984 | Generation of induced neuronal cells by the single reprogramming factor ASCL1 |
| Q92621823 | Genotyping, generation and proteomic profiling of the first human autosomal dominant osteopetrosis type II-specific induced pluripotent stem cells |
| Q38057758 | Human stem cell-derived astrocytes and their application to studying Nrf2-mediated neuroprotective pathways and therapeutics in neurodegeneration |
| Q41290146 | Increased nicotine response in iPSC-derived human neurons carrying the CHRNA5 N398 allele |
| Q26748907 | Induced Pluripotent Stem Cell Therapies for Cervical Spinal Cord Injury |
| Q37625840 | Loss of spastin function results in disease-specific axonal defects in human pluripotent stem cell-based models of hereditary spastic paraplegia |
| Q37304493 | Modeling neurological diseases with induced pluripotent cells reprogrammed from immortalized lymphoblastoid cell lines |
| Q38238081 | Modeling physiological and pathological human neurogenesis in the dish |
| Q38999345 | Neurotrophin Signaling and Stem Cells-Implications for Neurodegenerative Diseases and Stem Cell Therapy |
| Q26269862 | Rapid single-step induction of functional neurons from human pluripotent stem cells |
| Q55401574 | Rostrocaudal Areal Patterning of Human PSC-Derived Cortical Neurons by FGF8 Signaling. |
| Q31140540 | Statistical analysis of dendritic spine distributions in rat hippocampal cultures |
| Q34550570 | Stem Cell Therapies in Retinal Disorders. |
| Q26830610 | Synthetic biology and therapeutic strategies for the degenerating brain: Synthetic biology approaches can transform classical cell and gene therapies, to provide new cures for neurodegenerative diseases |
| Q90696674 | The fragile X mutation impairs homeostatic plasticity in human neurons by blocking synaptic retinoic acid signaling |
| Q37598422 | The utility of patient specific induced pluripotent stem cells for the modelling of Autistic Spectrum Disorders |
| Q39247380 | iPS cell modeling of Best disease: insights into the pathophysiology of an inherited macular degeneration. |
| Q37688424 | iPS cell technologies: significance and applications to CNS regeneration and disease |
| Q38185513 | iPS cells: a game changer for future medicine |